Insitro
South San Francisco
About Insitro
Insitro is an operator of a data-driven drug discovery and development company that utilizes machine learning and high-throughput biology to transform the way that drugs are discovered and delivered to patients. The company uses state-of-the-art technologies from bioengineering enabling it to generate high-throughput, functional genomic data sets and aligning them with patient data via novel machine learning methods, thereby building predictive models that can accelerate target selection and the design and development of effective therapeutics. In 2018, Daphne Koller established Insitro in South San Francisco, California..
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 251 – 500
- Estimated revenue: $1K – $10K
- Total funding: $643.0M
- Funding stage: Late Stage Venture
- Last round: Series C (Mar 2021)
- Website: insitro.com
Industries & Categories
Biotechnology, Health Care, Life Science, Machine Learning, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/insitro-40841 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.